This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Gc Corporation. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Azusa Miyagawa: Innovator in Antibacterial Technologies
Introduction
Azusa Miyagawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of antibacterial materials, holding 2 patents that showcase his innovative approach to polymer technology. His work is particularly relevant in the medical and dental industries, where effective antibacterial solutions are crucial.
Latest Patents
Miyagawa's latest patents include groundbreaking inventions such as antibacterial polymer particles and a dental curable composition. The antibacterial polymer particles patent describes a crosslinked copolymer that incorporates structural units derived from both monofunctional and polyfunctional monomers. This invention boasts a water absorption capacity of 3 g/g or more, making it highly effective for various applications. The dental curable composition patent outlines a formulation that includes polymerizable monomers and specifically treated inorganic particles, ensuring optimal performance in dental applications.
Career Highlights
Azusa Miyagawa is currently associated with Gc Corporation, a company known for its advancements in dental materials and technologies. His role at Gc Corporation allows him to further develop his innovative ideas and contribute to the company's mission of enhancing dental care through cutting-edge solutions.
Collaborations
Miyagawa collaborates with talented individuals such as Takumasa Kimura and Yuri Fukuyo, who contribute to his research and development efforts. Their combined expertise fosters a creative environment that drives innovation in antibacterial technologies.
Conclusion
Azusa Miyagawa's work exemplifies the importance of innovation in the field of antibacterial materials. His patents not only advance scientific knowledge but also have practical applications that can significantly impact healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
